3 hours Elevance Health (NYSE:ELV) Stock Rating Reaffirmed by Truist FinancialMarketBeat
Truist Financial reiterated a “buy” rating and set a $520.00 target price (down previously from $620.00) on shares of Elevance Health in a research report on Friday.
Health · NYSE · Science · Truist Financial Corp (TFC)
X